Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2026-02-27 @ 9:09 AM
Study NCT ID:
NCT02880956
Status:
COMPLETED
Last Update Posted:
2022-08-26
First Post:
2016-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Alzheimer's Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Early Alzheimer's Disease (AD) | View |
| None | Mild Cognitive Impairment (MCI) | View |
| None | Mild Alzheimer's Disease (AD) | View |
| None | Tau | View |
| None | Early dementia | View |
| None | Tauopathies | View |
| None | AD | View |
| None | Neurodegenerative diseases | View |
| None | Memory loss | View |
| None | Nervous system diseases | View |